| Patents for C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system (17,376) |
|---|
| 09/07/2004 | US6787570 Administering an aromatic or heteroaromatic substituted tertiaryamine compound to treat atherosclerosis, dyslipidemia, and other coronary artery diseases |
| 09/07/2004 | CA2105709C Substituted cyclohexane derivatives, processes for their preparation and the use of the compounds for treating diseases |
| 09/02/2004 | WO2004074305A2 Process for the production of 2-oxa-3-one androstane derivatives |
| 09/02/2004 | WO2004074294A1 Preparation of a trans-calanolide ketone intermediate and chiral sepatation of calanolide alcohols to give racemic calanolide a |
| 09/02/2004 | WO2004074273A1 Novel compounds |
| 09/02/2004 | WO2004074249A2 Synthesis of peloruside a and analogs thereof for use as antitumor agents |
| 09/02/2004 | WO2004073375A2 Podophyllotoxin derivatives as antitumor agents |
| 09/02/2004 | US20040171817 Thermal printing |
| 09/02/2004 | US20040171675 Antifungal agents of sordarin derivatives |
| 09/02/2004 | US20040171672 Synthetic salicylihalamides, apicularens and derivatives thereof |
| 09/02/2004 | US20040171662 Biaryl-type compounds, CD color fixing agent and method for determination of absolute configuration |
| 09/02/2004 | US20040171658 Blood coagulation factor Xa inhibition; such as 2-O-(3'-amidinobenzyl)-5-O-(3''-amidinophenyl)-1,4:3,6-dianhydrosorbitol |
| 09/02/2004 | US20040171638 Chemokine receptor binding heterocyclic compounds |
| 09/02/2004 | US20040171558 sulfamate; represented by topiramate; retinal embolism, ischemic optic neuropathy, macular degeneration, retinitis pigmentosa or Leber's disease |
| 09/02/2004 | CA2516393A1 Synthesis of peloruside a and analogs thereof for use as antitumor agents |
| 09/02/2004 | CA2515697A1 Process for the production of 2-oxa-3-one androstane derivatives |
| 09/01/2004 | EP1451195A1 3-biphenyl-substituted-3-substituted-4-ketolactam and ketolactone and their utilization as pesticide |
| 09/01/2004 | EP1451193A1 Podophyllotoxins as antiproliferative agents |
| 09/01/2004 | EP1451177A1 Substituted 2-pyrrolidine-2-yl-1h-indole derivatives for the treatment of migraine |
| 09/01/2004 | EP1450784A2 Hsp90-inhibiting zearalanol compounds and methods of producing and using same |
| 09/01/2004 | EP1347984B1 A process for the preparation of taxan derivatives |
| 09/01/2004 | EP1228024B1 Novel hydronaphthalene compounds, prepared by a rhodium catalyzed ring opening reaction in the presence of phosphine ligand |
| 09/01/2004 | CN1525962A De Rock Herman Augustinus |
| 09/01/2004 | CN1524858A Supersonic lixiviating nimbin |
| 08/31/2004 | US6784322 Contacting a solid support bound aryl diazonium salt with 3,6-dichorloquinone to form solid support-bound aryl quinone derivative, contacting it with a diazonium compound to form a an intermediate, repeating, terminating with a diazonium |
| 08/31/2004 | US6784301 Perylene-derivative based crystallization modifiers |
| 08/31/2004 | US6784210 Decyclization of oxabenzonorbornadienes or azabicyclic compounds in the presence of catalysts to form naphthalenes, such as 2-methoxy-1,2-dihydronaphthalen-1-ol, used as analgesics, anticarcinogens or viricides; catalysis |
| 08/31/2004 | US6784189 Potassium channel inhibitors and method |
| 08/31/2004 | CA2098076C Imidate prodrugs of pharmaceutically useful anticonvulsant sulfamates |
| 08/26/2004 | WO2004071506A1 Use of artemisinin for treating tumors induced by oncogenic viruses and for treating viral infections |
| 08/26/2004 | WO2004031168A3 Processes and intermediates for the preparation of optically active 3-amino-1-(2-thienyl)-1-propanol derivatives |
| 08/26/2004 | WO2004018438A3 Microbiocidal (e.g. fungicidal) 1,2,3-triazole derivatives |
| 08/26/2004 | WO2004017922B1 Keto cannabinoids with therapeutic indications |
| 08/26/2004 | US20040167208 Anticancer agents; arteriosclerosis; psoriasis |
| 08/26/2004 | US20040167141 Anticancer agents; antidiabetic agents; Alzheimer's disease |
| 08/26/2004 | US20040167083 Effector conjugates, methods for their preparation and their pharmaceutical use |
| 08/26/2004 | US20040167031 Arylphenyl-substituted cyclic ketoenols |
| 08/26/2004 | US20040166441 Optical information-recording medium, novel oxonol compound and method of recording information |
| 08/26/2004 | CA2515761A1 Use of artemisinin for treating tumors induced by oncogenic viruses and for treating viral infections |
| 08/25/2004 | EP1449435A1 Anthelmintic composition |
| 08/25/2004 | EP1448567A1 Method for the preparation of hexahydro-furo 2,3-b]furan-3-ol |
| 08/25/2004 | EP1448566A2 Chemokine receptor antagonists and methods of use thereof |
| 08/25/2004 | EP1448544A1 Substituted benzopyrans as selective estrogen receptor-beta agonists |
| 08/25/2004 | EP1448543A1 Products of condensations of hydroxycoumarin derivatives with aromatic and aliphatic dialdehydes, their preparation and antiviral action thereof |
| 08/25/2004 | EP1448541A2 Preparation and use of gamma-butyrolactones as cross-linking agents |
| 08/25/2004 | EP1448218A2 Beta-secretase inhibitors and methods of use |
| 08/19/2004 | WO2004069842A1 Process to prepare malayamycin derivatives |
| 08/19/2004 | WO2004069824A1 Pyrazole derivative |
| 08/19/2004 | WO2004069233A1 Breast cancer-resistant protein inhibitor |
| 08/19/2004 | WO2003087316A3 Novel derivatives of carnosic acid |
| 08/19/2004 | US20040162340 Without the use of ozone or toxic reagents, intermediate for AIDS drug |
| 08/19/2004 | US20040162337 Lactone-type acidic compounds |
| 08/19/2004 | US20040162323 Prostaglandin D2 antagonist |
| 08/19/2004 | US20040159265 Transition metal or silicon matrix in which particles of an organic pigment are homogeneously embedded or crosslinked; 3-methylidene-2,3-dihydro-indol-2-ones, quinacridone, indigo, diketopyrrolopyrrole, anthraquinone, perylene; thermostable |
| 08/19/2004 | DE10305098A1 New effector conjugates of epithilones useful to treat e.g. diseases associated with proliferative processes, neurodegenerative diseases, multiple sclerosis, Alzheimer's disease and rheumatoid arthritis |
| 08/19/2004 | CA2515135A1 Breast cancer-resistant protein inhibitor |
| 08/19/2004 | CA2515119A1 Pyrazole derivative |
| 08/18/2004 | EP1446406A2 Photochromic naphthopyrans for ophthalmic articles |
| 08/18/2004 | EP1446391A2 Preparation and use of carbohydrate-based ring structures with antimicrobial and cytostatic activity |
| 08/18/2004 | EP1446373A1 Method for preparing a composition containing at least an internal dehydrating product of a hydrogenated sugar |
| 08/18/2004 | CN1521747A Optical information-recording medium, novel oxonol compound |
| 08/18/2004 | CN1521258A Novel epothilones compound and its preparation method and application |
| 08/18/2004 | CN1162434C Improved process for rifampin high-density raw powder I type crystal |
| 08/17/2004 | US6777562 Preparation of a trans-calanolide ketone intermediate and chiral separation of calanolide alcohols to give racemic calanolide A |
| 08/17/2004 | US6777441 For therapy and prophylaxis |
| 08/17/2004 | CA2236582C Substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives |
| 08/12/2004 | WO2004066994A1 Anticancer agent |
| 08/12/2004 | WO2003093231A3 Tetrahydropyranyl cyclopentyl tetrahydroisoquinoline modulators of chemokine receptor activity |
| 08/12/2004 | US20040158081 Continuous process for the preparation of fructopyranose sulfamate derivatives |
| 08/12/2004 | US20040157893 Pyrazole compounds useful as protein kinase inhibitors |
| 08/12/2004 | US20040157844 6-azauracil derivatives as thyroid receptor ligands |
| 08/12/2004 | US20040156925 Plant proanthocyanidin extract effective at inhibiting utility |
| 08/11/2004 | EP1445257A1 Chromene compound |
| 08/11/2004 | EP1334092A4 Process for preparation of bicyclic and polycyclic molecules |
| 08/11/2004 | EP0869794B1 Substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives |
| 08/11/2004 | CN1520416A 碳水化合物衍生物 Carbohydrate derivatives |
| 08/11/2004 | CN1161358C 4 beta-benseleno-4-desoxy-4-demethylpodophyllotoxin derivant |
| 08/10/2004 | US6774142 May be administered along with rutin, a rutin congener and/or a rutin derivative. |
| 08/10/2004 | US6774141 Inhibit replication of retroviruses such as lymphadenopathy associated-, human immunodeficiency, and human t-cell leukemia/lymphoma viruses |
| 08/05/2004 | WO2004065520A1 Light-emitting device, condensed polycyclic compound used therein and method for producing same |
| 08/05/2004 | WO2004064745A2 Method of preparation of heterocyclic molecules with pharmaceutical pharmaceutical excipient cosmeceutical agrochemical and industrial uses |
| 08/05/2004 | WO2003057830A3 Compositions and methods for hydroxylating epothilones |
| 08/05/2004 | WO2003051303A3 The total synthesis of merrilactone a |
| 08/05/2004 | US20040152907 Heating a pentitol or hexitol sugar alcohol or monoanhydrosugar alcohol starting material until molten; dehydrating molten starting material in the presence of an acid catalyst to form an anhydrosugar alcohol mixture; purifying anhydrosugar alcohol from anhydrosugar alcohol mixture |
| 08/05/2004 | US20040152905 Useful in the preparation of oligomeric compounds |
| 08/05/2004 | US20040152767 Immunosuppressants; induction apoptosis |
| 08/05/2004 | US20040152766 Composition comprising demethylcantharidin in combination with platinum-containing anticancer agents and use thereof |
| 08/04/2004 | EP1200444B1 Novel xanthone compounds, their preparation and use as medicament |
| 08/04/2004 | EP0950059B1 Cyclic sulfone derivatives |
| 08/04/2004 | CN1517350A Method for producing hydroxy-phenylpropionic acid diester |
| 08/03/2004 | US6770673 Administering dimethylaminoarglabin or salt as antitumor agent |
| 07/29/2004 | WO2004063210A1 Novel anticonvulsant derivative salts |
| 07/29/2004 | WO2004062590A2 Bicyclic carbohydrates as antiprotozoal bioactive for the treatment of infections caused by parasites |
| 07/29/2004 | WO2004062568A2 Conjugate of losartan, valsartan, candesartan or eprosartan and a chelant as contrast agent |
| 07/29/2004 | WO2003024974A3 Process for preparing protease inhibitor intermediates |
| 07/29/2004 | CA2511682A1 Novel anticonvulsant derivative salts |
| 07/28/2004 | EP1441011A1 Energy transfer dye containing an aromatic-substituted xanthene dye as donor dye and/or acceptor dye |
| 07/28/2004 | EP1441010A1 Fluorinated xanthene derivatives |
| 07/28/2004 | EP1440973A2 Epothilone derivatives, preparation and use |
| 07/28/2004 | EP1440688A1 Peroxisome proliferator activated receptor ligands and process for producing the same |